This startup raised $250 million to help dogs live longer is drawing significant interest across the industry.
Longevity Fund-backed Loyal is working toward FDA approval of a drug that could help dogs live longer, healthier lives.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →